Palo Alto Investors LP Long-Term Concentrated

CIK: 0001306923 · Show all filings

Period: Q1 2023 (← Previous) (Next →)

Filing Date: May 15, 2023

Total Value ($000): $1,207,102 (100.0% shares, 0.0% debt)

Holdings (30)

BMRN BIOMARIN PHARMACEUTICAL INC 14.8%
Value ($000) $178,050 Shares 1,831,035 Est. Cost $83.16 Unrealized +24.7%
REVANCE THERAPEUTICS INC 14.1%
Value ($000) $169,753 Shares 5,270,209 Est. Cost $21.40 Unrealized
UTHR UNITED THERAPEUTICS CORP 11.6%
Value ($000) $140,538 Shares 627,514 Est. Cost $89.23 Unrealized +176.3%
FOLD AMICUS THERAPEUTICS INC 9.7%
Value ($000) $116,711 Shares 10,524,022 Est. Cost $9.63 Unrealized +28.1%
BIIB BIOGEN INC 8.8%
Value ($000) $106,008 Shares 381,282 Est. Cost $264.98 Unrealized +4.4%
INSM INSMED INC 8.3%
Value ($000) $100,416 Shares 5,889,491 Est. Cost $17.79 Unrealized +9.2%
STAA STAAR SURGICAL CO 7.1%
Value ($000) $86,161 Shares 1,347,322 Est. Cost $23.48 Unrealized +177.9%
PRTA PROTHENA CORP PLC 6.7%
Value ($000) $80,643 Shares 1,663,777 Est. Cost $21.46 Unrealized +146.2%
ACAD ACADIA PHARMACEUTICALS INC 3.8%
Value ($000) $45,277 Shares 2,405,793 Est. Cost $28.41 Unrealized -33.0%
SAGE THERAPEUTICS INC 3.0%
Value ($000) $36,065 Shares 859,517 Est. Cost $46.62 Unrealized
EHTH EHEALTH INC 2.1%
Value ($000) $25,173 Shares 2,689,379 Est. Cost $38.69 Unrealized -79.7%
ALGN ALIGN TECHNOLOGY INC 2.1%
Value ($000) $24,929 Shares 74,605 Est. Cost $149.18 Unrealized +97.8%
KARYOPHARM THERAPEUTICS INC 1.8%
Value ($000) $22,079 Shares 5,675,876 Est. Cost $16.36 Unrealized
ALKS ALKERMES PLC 1.4%
Value ($000) $17,010 Shares 603,400 Est. Cost $22.36 Unrealized +21.8%
SNDX SYNDAX PHARMACEUTICALS INC 1.1%
Value ($000) $12,938 Shares 612,600 Est. Cost $16.84 Unrealized +47.7%
PROVENTION BIO INC 0.8%
Value ($000) $9,418 Shares 390,800 Est. Cost $4.50 Unrealized
ANAB ANAPTYSBIO INC 0.8%
Value ($000) $9,383 Shares 431,224 Est. Cost $19.06 Unrealized +27.5%
GOSS GOSSAMER BIO INC 0.4%
Value ($000) $4,366 Shares 3,465,152 Est. Cost $2.02 Unrealized -5.4%
CYTK CYTOKINETICS INC 0.3%
Value ($000) $3,931 Shares 111,717 Est. Cost $6.71 Unrealized +507.7%
TVTX TRAVERE THERAPEUTICS INC 0.3%
Value ($000) $3,735 Shares 166,069 Est. Cost $23.56 Unrealized -9.8%
VNDA VANDA PHARMACEUTICALS INC 0.3%
Value ($000) $3,278 Shares 482,697 Est. Cost $11.21 Unrealized -37.3%
KEZAR LIFE SCIENCES INC 0.2%
Value ($000) $2,054 Shares 656,200 Est. Cost $5.16 Unrealized
NVCR NOVOCURE LTD 0.2%
Value ($000) $1,972 Shares 32,790 Est. Cost $79.91 Unrealized 0.0%
GRITSTONE ONCOLOGY INC 0.2%
Value ($000) $1,852 Shares 666,127 Est. Cost $9.42 Unrealized
ALDX ALDEYRA THERAPEUTICS INC 0.1%
Value ($000) $1,597 Shares 160,800 Est. Cost $7.10 Unrealized -0.4%
MIRM MIRUM PHARMACEUTICALS INC 0.1%
Value ($000) $1,554 Shares 64,700 Est. Cost $15.56 Unrealized +46.5%
RLMD RELMADA THERAPEUTICS INC 0.1%
Value ($000) $1,225 Shares 542,100 Est. Cost $3.45 Unrealized 0.0%
TCMD TACTILE SYSTEMS TECHNOLOGY I 0.0%
Value ($000) $445 Shares 27,100 Est. Cost $39.74 Unrealized -65.0%
PEAK BIO INC 0.0%
Value ($000) $314 Shares 497,528 Est. Cost $4.06 Unrealized
URGN UROGEN PHARMA LTD 0.0%
Value ($000) $226 Shares 24,500 Est. Cost $27.01 Unrealized -65.9%